There could be a variety of reasons
Real-world dosing and outcomes 6-month persister loss about 12-13% (Hankosky DOM 2025), broad-cohort about -9.8% (Adamidis Cureus 2026), telehealth completers near -23% (Duncan Obesity Pillars 2026)
No 5-Amino-1MQ is a small molecule (a quinolinium derivative), included in Durham Peptides' catalog because it engages a metabolic pathway central to longevity and adipose research that peptides don't directly target
Location Back Bay, Boston, MA Areas We Serve Boston, MA Back Bay, MA Beacon Hill, MA South End, MA North End, MA Fenway-Kenmore, MA Charlestown, MA Dorchester, MA Jamaica Plain, MA Allston, MA Brighton, MA West Roxbury, MA Roslindale, MA East Boston, MA South Boston, MA Mission Hill, MA Hyde Park, MA Mattapan, MA Seaport, MA Somerville, MA
Q: How does GHK-Cu compare to other peptides for skin and hair concerns
See the Wolverine Stack Protocol Why Source and Medical Supervision Matter This is where most BPC-157 conversations go off the rails